ABSTRACT
Indications: Pulmonary embolism, acute myocardial infarction Category: Thrombolytic Half-life: 83 minutes Clinically important, potentially hazardous interactions with: bivalirudin
Reactions
Skin Allergic reactions (sic) (4.4%) [3] Angioedema (>10%) [1] Bleeding [1] Diaphoresis (1-10%) Exanthems (1-5%) [2] Flushing (<1%) Pruritus (1-10%) Purpura Rash (sic) (1-10%) Urticaria (1-5%) [1] Vasculitis [7]
Eyes Periorbital edema (>10%)
Hematopoietic Ecchymoses
Other Anaphylactoid reactions (<1%) [1] Back pain [1] Headache Injection-site bleeding [1] Injection-site phlebitis Serum sickness [5] Stomatitis (following local application) Tongue edema (with hemorrhagic swelling)
Trade name: Flomax (Boehringer Ingelheim) Indications: Benign prostatic hypertrophy Category: Selective alpha-blocker Half-life: 9-13 hours Clinically important, potentially hazardous interactions with: vardenafil
Reactions
Skin Angioedema Eczema [1] Erythema multiforme [1] Pruritus Rash (sic)
Other Dizziness [1] Headache Priapism [1] Rhinitis [1] Tooth disorder (sic)
